Ponce-Cusi R, Lopez-Sanchez P, Maracaja-Coutinho V, Espinal-Enriquez J
Int J Mol Sci. 2024; 25(22).
PMID: 39596229
PMC: 11594411.
DOI: 10.3390/ijms252212163.
Speiser D, Heibges M, Besch L, Hilger C, Keinert M, Klein K
JMIR Form Res. 2023; 7:e41179.
PMID: 37083496
PMC: 10163406.
DOI: 10.2196/41179.
Jin T, Park K, Nam S, Yoo Y, Park W, Yun I
Int J Mol Sci. 2022; 23(7).
PMID: 35409110
PMC: 8998777.
DOI: 10.3390/ijms23073754.
Baranska A, Blaszczuk A, Kanadys W, Malm M, Drop K, Polz-Dacewicz M
Cancers (Basel). 2021; 13(22).
PMID: 34830807
PMC: 8616467.
DOI: 10.3390/cancers13225654.
Jonasch E, Walker C, Rathmell W
Nat Rev Nephrol. 2020; 17(4):245-261.
PMID: 33144689
PMC: 8172121.
DOI: 10.1038/s41581-020-00359-2.
Phenome-wide Burden of Copy-Number Variation in the UK Biobank.
Aguirre M, Rivas M, Priest J
Am J Hum Genet. 2019; 105(2):373-383.
PMID: 31353025
PMC: 6699064.
DOI: 10.1016/j.ajhg.2019.07.001.
Myopia in Chinese families shows linkage to 10q26.13.
Musolf A, Simpson C, Long K, Moiz B, Lewis D, Middlebrooks C
Mol Vis. 2018; 24:29-42.
PMID: 29383007
PMC: 5767476.
Neuroblastoma, a Paradigm for Big Data Science in Pediatric Oncology.
Salazar B, Balczewski E, Ung C, Zhu S
Int J Mol Sci. 2016; 18(1).
PMID: 28035989
PMC: 5297672.
DOI: 10.3390/ijms18010037.
BRCA mutations and survival in breast cancer: an updated systematic review and meta-analysis.
Zhu Y, Wu J, Zhang C, Sun S, Zhang J, Liu W
Oncotarget. 2016; 7(43):70113-70127.
PMID: 27659521
PMC: 5342539.
DOI: 10.18632/oncotarget.12158.
Genomic Biomarkers for Breast Cancer Risk.
Walsh M, Nathanson K, Couch F, Offit K
Adv Exp Med Biol. 2016; 882:1-32.
PMID: 26987529
PMC: 5016023.
DOI: 10.1007/978-3-319-22909-6_1.
The hallmarks of premalignant conditions: a molecular basis for cancer prevention.
Ryan B, Faupel-Badger J
Semin Oncol. 2016; 43(1):22-35.
PMID: 26970122
PMC: 4789096.
DOI: 10.1053/j.seminoncol.2015.09.007.
Cytogenetic analysis of a malignant triton tumour by comparative genomic hybridization (CGH) and review of the literature.
Koutsimpelas D, Brieger J, Heinrich U, Torzewski M, Sommer C, Mann W
Eur Arch Otorhinolaryngol. 2011; 268(9):1391-6.
PMID: 21643932
DOI: 10.1007/s00405-011-1658-z.
Harnessing synthetic lethal interactions in anticancer drug discovery.
Chan D, Giaccia A
Nat Rev Drug Discov. 2011; 10(5):351-64.
PMID: 21532565
PMC: 3652585.
DOI: 10.1038/nrd3374.
External quality assessment of tumour marker analysis: state of the art and consequences for estimating diagnostic sensitivity and specificity.
Reinauer H, Wood W
Ger Med Sci. 2009; 3:Doc02.
PMID: 19675719
PMC: 2703247.
Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosis.
Shah S, Freedman N, Zhang L, Crosslin D, Stone D, Haynes C
PLoS Genet. 2009; 5(1):e1000318.
PMID: 19119412
PMC: 2602734.
DOI: 10.1371/journal.pgen.1000318.
Finding genes underlying human disease.
Stein C, Elston R
Clin Genet. 2008; 75(2):101-6.
PMID: 18783406
PMC: 3057167.
DOI: 10.1111/j.1399-0004.2008.01083.x.
Ashkenazi Jews and breast cancer: the consequences of linking ethnic identity to genetic disease.
Brandt-Rauf S, Raveis V, Drummond N, Conte J, Rothman S
Am J Public Health. 2006; 96(11):1979-88.
PMID: 17018815
PMC: 1751808.
DOI: 10.2105/AJPH.2005.083014.
Biological indices in the assessment of breast cancer.
Leong A, Lee A
Clin Mol Pathol. 1995; 48(5):M221-38.
PMID: 16696013
PMC: 407976.
DOI: 10.1136/mp.48.5.m221.
Comparisons of case-selection approaches based on allele sharing and/or disease severity index: application to the GAW14 simulated data.
Liu C, Cupples L, Dupuis J
BMC Genet. 2006; 6 Suppl 1:S103.
PMID: 16451559
PMC: 1866836.
DOI: 10.1186/1471-2156-6-S1-S103.
Increasing the power and efficiency of disease-marker case-control association studies through use of allele-sharing information.
Fingerlin T, Boehnke M, Abecasis G
Am J Hum Genet. 2004; 74(3):432-43.
PMID: 14752704
PMC: 1182257.
DOI: 10.1086/381652.